0069-2025 : Comirnaty .225 mg/2.25ml Intramuscular Injection, Suspension
| NDC: | 0069-2025 |
| Labeler: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | Vaccine |
| Drug Name: | Comirnaty |
| Dosage Form: | Intramuscular Injection, Suspension |
| Application #: | BLA125742 |
| Rev. Date: |
NDC Package Codes:
- 0069-2025-10: 10 VIAL, GLASS IN 1 CARTON (0069‑2025‑10) > 2.25 ML IN 1 VIAL, GLASS (0069‑2025‑01)
- 0069-2025-25: 25 VIAL, GLASS IN 1 CARTON (0069‑2025‑25) > 2.25 ML IN 1 VIAL, GLASS (0069‑2025‑01)
Active Ingredients:
- Tozinameran
Dosage Strength:
- .225 mg/2.25mL
Related Products:
Based on records with the same trade name.- 0069-2362 Comirnaty .048 mg/.48ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
- 0069-2377 Comirnaty .042 mg/.418ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
- 0069-2392 Comirnaty .043 mg/.432ml Intramuscular Injection, Suspension by Pfizer Laboratories Div Pfizer Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0069-2007Next: 0069-2150 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.
